ResearcherNYU Langone HealthNo recent work listed

Gregory David

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-3371-4558; OpenAlex author ID A5100643219; NIH RePORTER profile ID 8199939.

Their work

Papers: 3 (first author 0, last author 3)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2014: 2 papers, 1 grant · 2015: none · 2016: 1 paper

Papers 3

The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/bs.acr.2016.05.006 ↗
Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. Last author DOI 10.1172/jci72619 ↗
SIN3B, the SASP, and pancreatic cancer. Last author DOI 10.4161/23723548.2014.969167 ↗

Grants 1

Role of cell cycle withdrawal in restricting pancreatic cancer progression. R21CA155736 ↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

David John Cantor · 2 shared papers, 2014
- Paper SIN3B, the SASP, and pancreatic cancer. DOI 10.4161/23723548.2014.969167 ↗
- Paper Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. DOI 10.1172/jci72619 ↗
Angelo Porciuncula · 1 shared paper, 2016
- Paper The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/bs.acr.2016.05.006 ↗
Maïté Rielland · 1 shared paper, 2014
- Paper Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. DOI 10.1172/jci72619 ↗
George Miller · 1 shared paper, 2014
- Paper Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression. DOI 10.1172/jci72619 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.